Billiontoone (NASDAQ:BLLN) SVP Bosch John Roderick Ten Sells 1,416 Shares

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $97.54, for a total value of $138,116.64. Following the sale, the senior vice president directly owned 25,051 shares of the company’s stock, valued at approximately $2,443,474.54. The trade was a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total value of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The shares were sold at an average price of $101.47, for a total transaction of $287,363.04.

Billiontoone Trading Up 0.3%

BLLN stock opened at $98.77 on Friday. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $150.44. The company has a market capitalization of $4.66 billion and a PE ratio of 141.10. The company’s 50-day simple moving average is $111.64 and its 200 day simple moving average is $95.81. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The business had revenue of $109.45 million during the quarter. As a group, sell-side analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on BLLN. BTIG Research reduced their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Wall Street Zen downgraded Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Canaccord Genuity Group began coverage on Billiontoone in a report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price on the stock. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Finally, Zacks Research downgraded Billiontoone from a “hold” rating to a “strong sell” rating in a research note on Monday, August 31st. Seven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $125.88.

Institutional Investors Weigh In On Billiontoone

Several institutional investors and hedge funds have recently added to or reduced their stakes in BLLN. Integrated Wealth Concepts LLC bought a new position in shares of Billiontoone in the 2nd quarter valued at $29,000. Rossby Financial LCC bought a new stake in shares of Billiontoone during the 4th quarter worth $25,000. MCF Advisors LLC lifted its position in shares of Billiontoone by 330.8% during the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after buying an additional 344 shares during the last quarter. Wells Fargo & Company MN acquired a new stake in Billiontoone in the fourth quarter valued at about $76,000. Finally, Smartleaf Asset Management LLC bought a new position in Billiontoone in the fourth quarter valued at about $80,000.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.